Skip to main content
. 2020 May 10;4(4):422–432. doi: 10.1002/ags3.12336

Table 1.

Patient Characteristics and Postoperative Complications (n = 300)

Characteristic  
Age a (y) 67.6 ± 9.1
Sex (Male/Female) 252 (84%)/48 (16%)
Performance Status (0/1/2/3) 32 (10.7%)/246 (82.0%)/21 (7.0%)/1 (0.3%)
Tumor location (Ut/Mt/Lt) 43 (14.3%)/171 (57.0%)/86 (28.7%)
Clinical stage b (I/II/III/IV) 72 (24%)/42 (14%)/155 (51.7%)/31 (10.3%)
Histological tumor type (SCC/AC) 295 (98.3%)/5 (1.67%)
Preoperative therapy (CT/CRT/None) 189 (63%)/30 (10%)/81 (27%)
Thoracic approach (Right thoracotomy/Thoracoscopic) 210 (70%)/90 (30%)
Lymph node dissection (Two fields/Three fields) 85 (28.3%)/215 (71.7%)
Route of reconstruction (Substernal/Posterior mediastinal) 49 (16.3%)/251 (83.7%)
Operative time (minutes) a 378 ± 92.0
Blood loss (g) a 183 ± 99.6
Postoperative complications No. (%)
Early‐phase complications
Anastomotic leakage 2 (0.67)
Vocal cord palsy 33 (12.0)
Atrial fibrillation 21 (7.0)
Delirium 10 (3.3)
Pneumonia 9 (3.0)
Chylothorax 9 (3.0)
Pulmonary thromboembolism 3 (1.0)
Ileus 3 (1.0)
Postoperative bleeding 2 (0.67)
Hepatic portal venous gas 1 (0.33)
Sick sinus syndrome 1 (0.33)
Esophageal hiatal hernia 1 (0.33)
Air leakage 1 (0.33)
Reoperation: air leakage, chylothorax, esophageal hiatal hernia 3 (1.0)
Hospital mortality 0 (0.0)
Late‐phase complications
Stenosis of anastomotic site 15 (5.0)
Nausea 11 (3.7)
Dumping syndrome 7 (2.3)
Ulceration of subtotal gastric tube 1 (0.33)

Abbreviations: Ut, Upper esophagus; Mt, Middle esophagus; Lt, Lower esophagus; SCC, Squamous cell carcinoma; AC, adenocarcinoma; CT, Chemotherapy; CRT, Chemoradiotherapy.

a

Mean ± standard deviation.

b

TNM Classification of Malignant Tumors, 7th ed.